Open AccessVEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients
Author(s) -
Yi Ding,
Leticia OliveiraFerrer,
Eike Vettorazzi,
Karen Legler,
Karin MildeLangosch,
Linn Woelber,
Anna Jaeger,
Katharina Prieske,
Volkmar Mueller,
Barbara Schmalfeldt,
Sascha Kuerti
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0269680
Subject(s) - bevacizumab , medicine , ovarian cancer , vascular endothelial growth factor , oncology , stage (stratigraphy) , biomarker , maintenance therapy , chemotherapy , cancer , gastroenterology , vegf receptors , biology , paleontology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom